Search research articles
Contact Us
Filters
Showing results (981-990 of 1,104) with videos related to
Page
of 111
Sort By:
American Journal of Hematology
|
January 11, 2020
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)
Ho Sup Lee, Kihyun Kim, Seok Jin Kim, et al.
Annals of Hematology
|
October 19, 2010
Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia
Yun-Gyoo Lee, Inho Kim, Jin Hee Kim, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
July 28, 2016
Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease
Oh Young Bang, Jong-Won Chung, Suk Jae Kim, et al.
Annals of Hematology
|
July 27, 2011
Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial
Hye Jin Kim, Sung-Soo Yoon, Dong Soon Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 5, 2012
Allogeneic hematopoietic stem cell transplant for adults over 40 years old with acquired aplastic anemia
Hawk Kim, Kyoo-Hyung Lee, Sung-Soo Yoon, et al.
International Journal of Hematology
|
May 26, 2020
Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study
Jongheon Jung, Yoon Seok Choi, Jae Hoon Lee, et al.
American Journal of Hematology
|
March 20, 2026
Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis
Nancy L Bartlett, Laurie H Sehn, Sarit Assouline, et al.
Journal of Cellular Biochemistry
|
September 16, 2004
L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60
Seong-Su Han, Kihyun Kim, Eun-Ryeong Hahm, et al.
Annals of Hematology
|
August 26, 2009
Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide
Youngil Koh, Soo-Mee Bang, Jae Hoon Lee, et al.
American Journal of Hematology
|
April 12, 2014
Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study
Kihyun Kim, Jae Hoon Lee, Jin Seok Kim, et al.
Page
of 111
Search research articles
Search
Showing results (981-990 of 1,104) with videos related to
Sort By:
Page
of 111
American Journal of Hematology
|
January 11, 2020
Pomalidomide, cyclophosphamide, and dexamethasone for elderly patients with relapsed and refractory multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)
Ho Sup Lee, Kihyun Kim, Seok Jin Kim, et al.
Annals of Hematology
|
October 19, 2010
Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia
Yun-Gyoo Lee, Inho Kim, Jin Hee Kim, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
July 28, 2016
Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease
Oh Young Bang, Jong-Won Chung, Suk Jae Kim, et al.
Annals of Hematology
|
July 27, 2011
Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial
Hye Jin Kim, Sung-Soo Yoon, Dong Soon Lee, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 5, 2012
Allogeneic hematopoietic stem cell transplant for adults over 40 years old with acquired aplastic anemia
Hawk Kim, Kyoo-Hyung Lee, Sung-Soo Yoon, et al.
International Journal of Hematology
|
May 26, 2020
Autologous stem cell transplantation in elderly patients with multiple myeloma in Korea: the KMM1807 study
Jongheon Jung, Yoon Seok Choi, Jae Hoon Lee, et al.
American Journal of Hematology
|
March 20, 2026
Fixed-Duration Subcutaneous Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma: Pivotal Phase 2 Primary Analysis
Nancy L Bartlett, Laurie H Sehn, Sarit Assouline, et al.
Journal of Cellular Biochemistry
|
September 16, 2004
L-ascorbic acid represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60
Seong-Su Han, Kihyun Kim, Eun-Ryeong Hahm, et al.
Annals of Hematology
|
August 26, 2009
Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide
Youngil Koh, Soo-Mee Bang, Jae Hoon Lee, et al.
American Journal of Hematology
|
April 12, 2014
Clinical profiles of multiple myeloma in Asia-An Asian Myeloma Network study
Kihyun Kim, Jae Hoon Lee, Jin Seok Kim, et al.
Page
of 111